Envestnet Asset Management’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-13,118
| Closed | -$617K | – | 4140 |
|
|
2023
Q2 | $617K | Buy |
13,118
+964
| +8% | +$45.3K | ﹤0.01% | 3095 |
|
|
2023
Q1 | $510K | Buy |
12,154
+1,153
| +10% | +$48.4K | ﹤0.01% | 3130 |
|
|
2022
Q4 | $420K | Buy |
11,001
+488
| +5% | +$18.6K | ﹤0.01% | 3196 |
|
|
2022
Q3 | $412K | Buy |
10,513
+242
| +2% | +$9.48K | ﹤0.01% | 3137 |
|
|
2022
Q2 | $332K | Sell |
10,271
-1,241
| -11% | -$40.1K | ﹤0.01% | 3304 |
|
|
2022
Q1 | $381K | Sell |
11,512
-11,436
| -50% | -$378K | ﹤0.01% | 3292 |
|
|
2021
Q4 | $976K | Buy |
22,948
+11,358
| +98% | +$483K | ﹤0.01% | 2646 |
|
|
2021
Q3 | $514K | Sell |
11,590
-1,419
| -11% | -$62.9K | ﹤0.01% | 2948 |
|
|
2021
Q2 | $739K | Buy |
13,009
+4,395
| +51% | +$250K | ﹤0.01% | 2725 |
|
|
2021
Q1 | $645K | Buy |
8,614
+5,116
| +146% | +$383K | ﹤0.01% | 2693 |
|
|
2020
Q4 | $303K | Buy |
+3,498
| New | +$303K | ﹤0.01% | 2920 |
|
|
2020
Q1 | – | Sell |
-6,228
| Closed | -$450K | – | 3116 |
|
|
2019
Q4 | $450K | Sell |
6,228
-6,185
| -50% | -$447K | ﹤0.01% | 2506 |
|
|
2019
Q3 | $1.74M | Buy |
12,413
+954
| +8% | +$134K | ﹤0.01% | 1630 |
|
|
2019
Q2 | $2.1M | Buy |
11,459
+2,135
| +23% | +$391K | ﹤0.01% | 1525 |
|
|
2019
Q1 | $1.48M | Buy |
9,324
+1,835
| +25% | +$292K | ﹤0.01% | 1639 |
|
|
2018
Q4 | $717K | Buy |
+7,489
| New | +$717K | ﹤0.01% | 1933 |
|
|
2018
Q3 | – | Sell |
-6,197
| Closed | -$970K | – | 2346 |
|
|
2018
Q2 | $970K | Buy |
6,197
+3,714
| +150% | +$581K | ﹤0.01% | 1069 |
|
|
2018
Q1 | $400K | Sell |
2,483
-141
| -5% | -$22.7K | ﹤0.01% | 1290 |
|
|
2017
Q4 | $432K | Sell |
2,624
-282
| -10% | -$46.4K | ﹤0.01% | 1551 |
|
|
2017
Q3 | $182K | Buy |
2,906
+1,204
| +71% | +$75.4K | ﹤0.01% | 1875 |
|
|
2017
Q2 | $136K | Sell |
1,702
-6
| -0.4% | -$479 | ﹤0.01% | 2019 |
|
|
2017
Q1 | $122K | Sell |
1,708
-61
| -3% | -$4.36K | ﹤0.01% | 2112 |
|
|
2016
Q4 | $90K | Buy |
+1,769
| New | +$90K | ﹤0.01% | 2227 |
|